Loading...
Header Logo
Keywords
Last Name
Institution

DAVID G POPLACK

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Hematology & Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    U01HD037242     (POPLACK, DAVID G.)Jan 7, 1999 - Dec 31, 2003
    NIH/NICHD
    PEDIATRIC PHARMACOLOGY RESEARCH UNIT
    Role: Principal Investigator

    U10HD037242     (POPLACK, DAVID G.)Jan 7, 1999 - Dec 31, 2010
    NIH/NICHD
    TCH/BCM Pediatric Pharmacology Research Unit
    Role: Principal Investigator

    K12CA090433     (BLANEY, SUSAN M.)Apr 1, 2001 - Jun 30, 2022
    NIH/NCI
    Pediatric Oncology Clinical Research Training Program
    Role: Co-Principal Investigator

    T32CA115303     (POPLACK, DAVID G.)Aug 4, 2006 - Jun 30, 2011
    NIH/NCI
    Pediatric Oncology Research Training Program
    Role: Principal Investigator

    H75DP001826     (POPLACK, DAVID G.)Sep 1, 2008 - Aug 31, 2010
    CDC/NCCDPHP
    EXPANDING PEDIATRIC ONCOLOGY SERVICES AND NURSING EDUCATION OUTREACH IN SOUTH TEX
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Scheurer ME, Lupo PJ, Schüz J, Spector LG, Wiemels JL, Aplenc R, Gramatges MM, Schiffman JD, Pombo-de-Oliveira MS, Yang JJ, Heck JE, Metayer C, Orjuela-Grimm MA, Bona K, Aristizabal P, Austin MT, Rabin KR, Russell HV, Poplack DG. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110. PMID: 29737912.
      View in: PubMed
    2. Gramatges MM, Bonaduce de Nigris F, King J, Horowitz ME, Fordis M, Poplack DG. Improving Childhood Cancer Survivor Care Through Web-Based Platforms. Oncology (Williston Park). 2018 01 15; 32(1):e1-e10. PMID: 29447422.
      View in: PubMed
    3. Poplack DG, Fordis M, Landier W, Bhatia S, Hudson MM, Horowitz ME. Childhood cancer survivor care: development of the Passport for Care. Nat Rev Clin Oncol. 2014 12; 11(12):740-50. PMID: 25348788.
      View in: PubMed
    4. Slone JS, Agrawal AK, Mehta PS, Mazhani L, Motumise K, Anabwani G, Poplack DG. Reply to "childhood cancer in Africa". Pediatr Blood Cancer. 2014 Aug; 61(8):1524. PMID: 24519963.
      View in: PubMed
    5. Marsland T, Arena F, Yeilding A, Glodé M, Ellis L, Yu J, Henderson C, Wagman L, Piver S, Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W. Perspective on...the new PSA screening recommendations. Oncology (Williston Park). 2011 Nov 15; 25(12):1183, 1187-8, 1190. PMID: 22229211.
      View in: PubMed
    6. Rabin KR, Poplack DG. Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15; 25(4):328-35. PMID: 21618954.
      View in: PubMed
    7. Frugé E, Lakoski JM, Luban N, Lipton JM, Poplack DG, Hagey A, Felgenhauer J, Hilden J, Margolin J, Vaiselbuh SR, Sakamoto KM. Increasing diversity in pediatric hematology/oncology. Pediatr Blood Cancer. 2011 Jul 15; 57(1):147-52. PMID: 21284078.
      View in: PubMed
    8. Frugé E, Mahoney DH, Poplack DG, Horowitz ME. Leadership: "They never taught me this in medical school". J Pediatr Hematol Oncol. 2010 May; 32(4):304-8. PMID: 20445418.
      View in: PubMed
    9. Horowitz ME, Fordis M, Krause S, McKellar J, Poplack DG. Passport for care: implementing the survivorship care plan. J Oncol Pract. 2009 May; 5(3):110-2. PMID: 20856747.
      View in: PubMed
    10. Nathan PC, Whitcomb T, Wolters PL, Steinberg SM, Balis FM, Brouwers P, Hunsberger S, Feusner J, Sather H, Miser J, Odom LF, Poplack D, Reaman G, Bleyer WA. Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504. PMID: 17169794.
      View in: PubMed
    11. Poplack DG. Introduction: pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):253-4. PMID: 16197715.
      View in: PubMed
    12. Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, Poplack DG. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63. PMID: 15735131.
      View in: PubMed
    13. Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9. PMID: 15494606.
      View in: PubMed
    14. Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 01; 21(1):143-7. PMID: 12506183.
      View in: PubMed
    15. Berg SL, Poplack DG. Treatment of Meningeal Malignancy. Oncologist. 1996; 1(1 & 2):56-61. PMID: 10387969.
      View in: PubMed
    POPLACK's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description